Healthcare
ICU Medical, Inc.(ICUI)
Live Price
Offline$136.14
-3.01% today
1Y Change
+8.24%
Window
Jun 25, 2025 โ Jun 24, 2026
- Market Cap
- $2.98B
- Revenue Growth
- -6.4%
- EPS Growth
- +100.6%
- Dividend Yield
- 0.0%
Coverage: 251 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
ICU Medical, Inc. (ICUI) is a Healthcare stock with a market cap of $2.98B and listed on NASDAQ. The stock last traded around $136.14 and up 8.2% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of -6.4%, EPS growth of +100.6%, a dividend yield of 0.0%. What stands out right now is revenue -6.4%, EPS +100.6%, free cash flow -26.4% with operating margin 2.8% and ROIC 0.4%. Valuation already assumes a fairly strong business story at P/E 4020.1 and price/sales 1.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ICUI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-6.4% vs +7.6% peer median
Operating Margin
Below sector median
+2.8% vs +19.4% peer median
P/E
Above sector median
4020.1 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -6.4% and EPS is at +100.6%, with operating margin around 2.8%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +4.8% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | -3.5% | +6.8% | +15.6% |
2026 Feb 19, 2026 | +13.7% | +4.9% | +0.7% | -15.4% |
2025 Nov 6, 2025 | +42.0% | +8.1% | +6.8% | +9.9% |
Benchmark Edge
ICUI vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ICUI
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ICUI Max Drawdown
-27.18%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ICUI and SPY.
Company Overview
ICU Medical, Inc.
NASDAQ Global Select
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
- Leadership
- Vivek Jain
- IPO Date
- Mar 31, 1992
- Employees
- 15.0k
- Street Address
- 951 Calle Amanecer
- Mailing
- San Clemente, CA, 92673
- Region
- San Clemente, CA, US
- Reporting Currency
- USD
- Investor Line
- 949 366 2183
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 4020.1
- EV/EBITDA
- 13.7
- Price/Sales
- 1.3
- Price/Book
- 1.4
Growth
- Revenue
- -6.4%
- EPS
- +100.6%
- Free Cash Flow
- -26.4%
Profitability
- Gross Margin
- 36.8%
- Operating Margin
- 2.8%
- Net Margin
- 0.0%
- ROE
- 0.0%
- ROIC
- 0.4%
Balance Sheet
- Debt/Equity
- 0.66
- Current Ratio
- 2.36
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.